DE3650716T2 - Trimethoprim und ein Sulfonamid enthaltende Tabletten - Google Patents

Trimethoprim und ein Sulfonamid enthaltende Tabletten

Info

Publication number
DE3650716T2
DE3650716T2 DE3650716T DE3650716T DE3650716T2 DE 3650716 T2 DE3650716 T2 DE 3650716T2 DE 3650716 T DE3650716 T DE 3650716T DE 3650716 T DE3650716 T DE 3650716T DE 3650716 T2 DE3650716 T2 DE 3650716T2
Authority
DE
Germany
Prior art keywords
sulfonamide
tablets containing
containing trimethoprim
trimethoprim
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3650716T
Other languages
English (en)
Other versions
DE3650716D1 (de
Inventor
Hong Sheng Tan
Bernardus Bartholomeus Wegman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Europe BV
Original Assignee
Yamanouchi Europe BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Europe BV filed Critical Yamanouchi Europe BV
Application granted granted Critical
Publication of DE3650716D1 publication Critical patent/DE3650716D1/de
Publication of DE3650716T2 publication Critical patent/DE3650716T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
DE3650716T 1985-05-02 1986-04-07 Trimethoprim und ein Sulfonamid enthaltende Tabletten Expired - Lifetime DE3650716T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP85200692A EP0199855A1 (de) 1985-05-02 1985-05-02 Trimethoprim und ein Sulfonamid enthaltende Tabletten

Publications (2)

Publication Number Publication Date
DE3650716D1 DE3650716D1 (de) 1999-04-15
DE3650716T2 true DE3650716T2 (de) 1999-07-22

Family

ID=8194017

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3650716T Expired - Lifetime DE3650716T2 (de) 1985-05-02 1986-04-07 Trimethoprim und ein Sulfonamid enthaltende Tabletten

Country Status (8)

Country Link
US (2) US4711777A (de)
EP (1) EP0199855A1 (de)
JP (1) JPS6219A (de)
AT (1) ATE177320T1 (de)
DE (1) DE3650716T2 (de)
DK (1) DK197086A (de)
GR (1) GR861148B (de)
PT (1) PT82487B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0199855A1 (de) * 1985-05-02 1986-11-05 Gist-Brocades N.V. Trimethoprim und ein Sulfonamid enthaltende Tabletten
US4894239A (en) * 1987-06-02 1990-01-16 Takeda Chemical Industries, Ltd. Sustained-release preparation and production thereof
US5049394A (en) * 1987-09-11 1991-09-17 E. R. Squibb & Sons, Inc. Pharmaceutical composition containing high drug load and method for preparing same
JP2836878B2 (ja) 1988-08-24 1998-12-14 スリピアン，マービン，ジェイ 生分解性高分子材料による管腔内封止
US5749915A (en) * 1988-08-24 1998-05-12 Focal, Inc. Polymeric endoluminal paving process
US5256699A (en) * 1988-10-18 1993-10-26 Ciba-Geify Corporation Dispersible tablet formulation of diclofenac acid free base
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition
SE9003903D0 (sv) * 1990-12-07 1990-12-07 Astra Ab New pharmaceutical formulations
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
GB2257363B (en) * 1991-01-30 1994-09-28 Wellcome Found Water dispersible tablets containing acyclovir
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
JPH0710747A (ja) * 1993-04-28 1995-01-13 Takeda Chem Ind Ltd 固形製剤およびその製造方法
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US5853383A (en) * 1995-05-03 1998-12-29 Alza Corporation Preparation for formulations for electrotransport drug delivery
EP1429728A1 (de) * 2001-08-29 2004-06-23 SRL Technologies, Inc. Zubereitungen mit verzögerter freisetzung
DE10248652A1 (de) * 2002-10-18 2004-04-29 Solvay Interox Gmbh Verfahren zur Herstellung von staubfreien Erdalkaliperoxiden
CN112190557B (zh) * 2020-09-18 2022-08-09 河北君临药业有限公司 一种复方磺胺甲噁唑片及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091574A (en) * 1961-09-05 1963-05-28 Bristol Myers Co Tablet disintegrants
US4209513A (en) * 1974-02-14 1980-06-24 Burroughs Wellcome Co. Tablet formulation
GB2067900B (en) * 1980-01-25 1983-06-22 Ddsa Pharmaceuticals Ltd Medicinal tablets
EP0199855A1 (de) * 1985-05-02 1986-11-05 Gist-Brocades N.V. Trimethoprim und ein Sulfonamid enthaltende Tabletten

Also Published As

Publication number Publication date
PT82487A (en) 1986-05-01
PT82487B (pt) 1989-01-17
EP0199855A1 (de) 1986-11-05
GR861148B (en) 1986-08-14
US4711777A (en) 1987-12-08
DE3650716D1 (de) 1999-04-15
DK197086A (da) 1986-11-03
US4774083A (en) 1988-09-27
DK197086D0 (da) 1986-04-30
JPS6219A (ja) 1987-01-06
ATE177320T1 (de) 1999-03-15

Similar Documents

Publication Publication Date Title
DE3650716T2 (de) Trimethoprim und ein Sulfonamid enthaltende Tabletten
DE3650721T2 (de) Endmodifizierte Blockcopolymere enthaltende Zusammensetzungen
BE890028A (fr) Poudre a base de sel d'addition d'acide de bacampicilline-micro-encapsule et composition pharmaceutique la contenant
MX163269B (es) Procedimiento para la polimerizacion en masa de diciclopentadieno
DE3677062D1 (de) Quelle geladener teilchen.
FR2588099B1 (fr) Compositions photoresistantes et ethers-oxydes de vinylaryle et d'organomethyle-t-substitue
MX164826B (es) Composicion de cloruro de vinilideno y pelicula hecha a partir de la misma
KR870700005A (ko) 하나이상의 활성성분을 함유하는 살충제 조성물
IT8521603A0 (it) Composizioni farmaceutiche contenenti come principi attivi flavanolignani e fosfolipidi.
IT1116524B (it) Procedimento di preparazione e composizione per la prevenzione ed il trattamento dell'artrite reumatoide e simili
DK284585A (da) 1,4-dihydropyrinderivater, fremgangsmaade til fremstilling af saadanne forbindelser samt laegemiddel indeholdende disse
DK112287D0 (da) Anvendelse af 2-alkoxy-n-(1-azabicyclo-oe2,2,2aaoct-3-yl)-benzamider og -thiobenzamider samt farmaceutisk acceptable syreadditionssalte deraf som laegemidler
NO862942D0 (no) Fremgangsmaate for fremstilling av kalsiumfluorsilikat.
IL84551A (en) Peptides,their preparation and pharmaceutical compositions containing them
LV10153A (lv) Sastavs seklu dezinfekcijai
IT1216056B (it) Composizioni farmaceutiche contenenti timosina alfa 1.
NO893326L (no) Fremgangsmaate for noeytralisering av svovelsyre inneholdende sinkioner.
IT8222593A0 (it) Procedimento di preparazione dell'erbicida phenmedipham.
DK423385D0 (da) Laegemiddel samt anvendelse af alfa-interferoner til fremstilling af et middel til behandling af diarre
IT1215261B (it) Composizioni farmaceutiche adattivita' antigalattopoietica.
FR2592078B1 (fr) Construction modulaire tridimensionnelle de maisons ou d'immeubles
OA08197A (fr) Variété de clémentinier précoce "Ripetri".
DK86488D0 (da) Monobasisk phosphatsalt af dobutamin, fremgangsmaade til fremstilling af et saadant salt samt farmaceutisk praeparat indeholdende saltet
IT8622051A0 (it) Composizioni farmaceutiche adattivita' cicatrizzante.
IT8620072A0 (it) Sale dell'acido 2',4'-difluoro-4-idrossi-3-bifenilcarbossilico, sua preparazione e composizioni farmaceutiche che lo contengono.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition